The public record · 119th Congress

Next GEN Act of 2026

The Congressional Research Service has not published a summary of this measure.

Other titles

the names this measure carries besides the one at the top of this page, each with the record's own label for it. The collection includes titles given to parts of a bill as well as to the whole.

To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.Official Title as Introduced

Next GEN Act of 2026Short Title(s) as Introduced

Next Generation Medicines Act of 2026Short Title(s) as Introduced

Legislative history

H.R. 8857·House·Bill·Health

Rep. Joseph D. Morelle(Democratic-New York-25)·

May 15, 2026

IntroducedIntroduced in House

May 15, 2026

HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

May 15, 2026

Documents

Everything Congress printed about this measure. A bill is reprinted each time it changes, the Congressional Research Service summarizes each version, and the committee that reports a bill files its own written account of it.

Bill text

May 15, 2026As introduced in the House